April 20, 2014 4:20 PM ET

Pharmaceuticals

Company Overview of Ception Therapeutics, Inc.

Company Overview

Ception Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes new drugs. It offers Reslizumab for eosinophilic inflammatory conditions. The company also provides Anti-TNF, a class of small molecule anti-TNF receptor agents with the potential to be orally administered. Ception Therapeutics, Inc. was founded in 2004 and is based in Malvern, Pennsylvania. As of April 5, 2010, Ception Therapeutics, Inc. operates as a subsidiary of Cephalon, Inc.

101 Lindenwood Drive

Suite 400

Valleybrooke III

Malvern, PA 19355

United States

Founded in 2004

Phone:

610-640-2940

Fax:

610-640-2945

Key Executives for Ception Therapeutics, Inc.

Vice President of Regulatory Affairs
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Desert West Marketing Inc United States
CerRx Inc. United States
Bioplus Pharmaceuticals Inc. United States
Carter-Wallace, Inc. United States
Prevention Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ception Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.